nodes	percent_of_prediction	percent_of_DWPC	metapath
Ixabepilone—TUBB4A—Vincristine—peripheral nervous system neoplasm	0.0913	0.114	CbGbCtD
Ixabepilone—TUBB6—Vincristine—peripheral nervous system neoplasm	0.0913	0.114	CbGbCtD
Ixabepilone—TUBB2A—Vincristine—peripheral nervous system neoplasm	0.0913	0.114	CbGbCtD
Ixabepilone—TUBB3—Vincristine—peripheral nervous system neoplasm	0.0913	0.114	CbGbCtD
Ixabepilone—TUBB8—Vincristine—peripheral nervous system neoplasm	0.0913	0.114	CbGbCtD
Ixabepilone—TUBB2B—Vincristine—peripheral nervous system neoplasm	0.0913	0.114	CbGbCtD
Ixabepilone—TUBB—Vincristine—peripheral nervous system neoplasm	0.0764	0.0955	CbGbCtD
Ixabepilone—TUBB4B—Vincristine—peripheral nervous system neoplasm	0.0764	0.0955	CbGbCtD
Ixabepilone—TUBB1—Vincristine—peripheral nervous system neoplasm	0.0764	0.0955	CbGbCtD
Ixabepilone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00763	0.00954	CbGbCtD
Ixabepilone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00709	0.00887	CbGbCtD
Ixabepilone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00326	0.00407	CbGbCtD
Ixabepilone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00298	0.00373	CbGbCtD
Ixabepilone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00204	0.00254	CbGbCtD
Ixabepilone—TUBB6—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	0.000732	0.151	CbGdCrCtD
Ixabepilone—TUBB6—Vitamin A—Tretinoin—peripheral nervous system neoplasm	0.000732	0.151	CbGdCrCtD
Ixabepilone—TUBB6—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	0.000555	0.115	CbGdCrCtD
Ixabepilone—TUBB6—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.000512	0.106	CbGdCrCtD
Ixabepilone—TUBB6—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000512	0.106	CbGdCrCtD
Ixabepilone—TUBB6—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.000512	0.106	CbGdCrCtD
Ixabepilone—TUBB6—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000512	0.106	CbGdCrCtD
Ixabepilone—TUBB6—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000388	0.0801	CbGdCrCtD
Ixabepilone—TUBB6—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000388	0.0801	CbGdCrCtD
Ixabepilone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000116	0.000595	CcSEcCtD
Ixabepilone—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000116	0.000594	CcSEcCtD
Ixabepilone—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000116	0.000593	CcSEcCtD
Ixabepilone—Cough—Etoposide—peripheral nervous system neoplasm	0.000116	0.000592	CcSEcCtD
Ixabepilone—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000116	0.000592	CcSEcCtD
Ixabepilone—Headache—Topotecan—peripheral nervous system neoplasm	0.000116	0.000591	CcSEcCtD
Ixabepilone—Rash—Tretinoin—peripheral nervous system neoplasm	0.000115	0.00059	CcSEcCtD
Ixabepilone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000115	0.00059	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000115	0.00059	CcSEcCtD
Ixabepilone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000115	0.00059	CcSEcCtD
Ixabepilone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000115	0.00059	CcSEcCtD
Ixabepilone—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000115	0.000589	CcSEcCtD
Ixabepilone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000115	0.000588	CcSEcCtD
Ixabepilone—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000587	CcSEcCtD
Ixabepilone—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000115	0.000587	CcSEcCtD
Ixabepilone—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000587	CcSEcCtD
Ixabepilone—Headache—Tretinoin—peripheral nervous system neoplasm	0.000115	0.000587	CcSEcCtD
Ixabepilone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000115	0.000587	CcSEcCtD
Ixabepilone—Pain—Vincristine—peripheral nervous system neoplasm	0.000114	0.000585	CcSEcCtD
Ixabepilone—Constipation—Vincristine—peripheral nervous system neoplasm	0.000114	0.000585	CcSEcCtD
Ixabepilone—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000585	CcSEcCtD
Ixabepilone—Rash—Melphalan—peripheral nervous system neoplasm	0.000114	0.000583	CcSEcCtD
Ixabepilone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000114	0.000582	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000113	0.00058	CcSEcCtD
Ixabepilone—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000113	0.000578	CcSEcCtD
Ixabepilone—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000113	0.000576	CcSEcCtD
Ixabepilone—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000575	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000112	0.000574	CcSEcCtD
Ixabepilone—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00011	0.000565	CcSEcCtD
Ixabepilone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00011	0.000564	CcSEcCtD
Ixabepilone—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.000561	CcSEcCtD
Ixabepilone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.000561	CcSEcCtD
Ixabepilone—Nausea—Topotecan—peripheral nervous system neoplasm	0.00011	0.000561	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000109	0.000559	CcSEcCtD
Ixabepilone—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000559	CcSEcCtD
Ixabepilone—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000557	CcSEcCtD
Ixabepilone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000109	0.000556	CcSEcCtD
Ixabepilone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000109	0.000556	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000108	0.000551	CcSEcCtD
Ixabepilone—Infection—Etoposide—peripheral nervous system neoplasm	0.000107	0.00055	CcSEcCtD
Ixabepilone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000107	0.000549	CcSEcCtD
Ixabepilone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000107	0.000549	CcSEcCtD
Ixabepilone—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000546	CcSEcCtD
Ixabepilone—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000544	CcSEcCtD
Ixabepilone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000106	0.000543	CcSEcCtD
Ixabepilone—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000106	0.000542	CcSEcCtD
Ixabepilone—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000106	0.000541	CcSEcCtD
Ixabepilone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000106	0.000541	CcSEcCtD
Ixabepilone—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000105	0.000539	CcSEcCtD
Ixabepilone—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000105	0.000538	CcSEcCtD
Ixabepilone—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000532	CcSEcCtD
Ixabepilone—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000532	CcSEcCtD
Ixabepilone—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000103	0.000528	CcSEcCtD
Ixabepilone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000103	0.000526	CcSEcCtD
Ixabepilone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000102	0.000524	CcSEcCtD
Ixabepilone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000102	0.000523	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000102	0.000522	CcSEcCtD
Ixabepilone—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000518	CcSEcCtD
Ixabepilone—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000101	0.000518	CcSEcCtD
Ixabepilone—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000517	CcSEcCtD
Ixabepilone—Pain—Cisplatin—peripheral nervous system neoplasm	0.000101	0.000517	CcSEcCtD
Ixabepilone—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000516	CcSEcCtD
Ixabepilone—Neutropenia—Epirubicin—peripheral nervous system neoplasm	9.97e-05	0.000511	CcSEcCtD
Ixabepilone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	9.95e-05	0.000509	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	9.91e-05	0.000507	CcSEcCtD
Ixabepilone—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	9.87e-05	0.000505	CcSEcCtD
Ixabepilone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	9.84e-05	0.000504	CcSEcCtD
Ixabepilone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	9.81e-05	0.000502	CcSEcCtD
Ixabepilone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	9.72e-05	0.000497	CcSEcCtD
Ixabepilone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	9.65e-05	0.000494	CcSEcCtD
Ixabepilone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	9.65e-05	0.000494	CcSEcCtD
Ixabepilone—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	9.61e-05	0.000492	CcSEcCtD
Ixabepilone—Asthenia—Vincristine—peripheral nervous system neoplasm	9.58e-05	0.000491	CcSEcCtD
Ixabepilone—Pneumonia—Epirubicin—peripheral nervous system neoplasm	9.57e-05	0.00049	CcSEcCtD
Ixabepilone—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	9.51e-05	0.000487	CcSEcCtD
Ixabepilone—Infestation—Epirubicin—peripheral nervous system neoplasm	9.51e-05	0.000487	CcSEcCtD
Ixabepilone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	9.51e-05	0.000487	CcSEcCtD
Ixabepilone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	9.48e-05	0.000485	CcSEcCtD
Ixabepilone—Rash—Dactinomycin—peripheral nervous system neoplasm	9.43e-05	0.000483	CcSEcCtD
Ixabepilone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	9.41e-05	0.000481	CcSEcCtD
Ixabepilone—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	9.37e-05	0.00048	CcSEcCtD
Ixabepilone—Renal failure—Epirubicin—peripheral nervous system neoplasm	9.35e-05	0.000479	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	9.34e-05	0.000478	CcSEcCtD
Ixabepilone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	9.34e-05	0.000478	CcSEcCtD
Ixabepilone—Fatigue—Etoposide—peripheral nervous system neoplasm	9.33e-05	0.000478	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	9.32e-05	0.000477	CcSEcCtD
Ixabepilone—Stomatitis—Epirubicin—peripheral nervous system neoplasm	9.27e-05	0.000475	CcSEcCtD
Ixabepilone—Jaundice—Epirubicin—peripheral nervous system neoplasm	9.27e-05	0.000475	CcSEcCtD
Ixabepilone—Pain—Etoposide—peripheral nervous system neoplasm	9.25e-05	0.000474	CcSEcCtD
Ixabepilone—Constipation—Etoposide—peripheral nervous system neoplasm	9.25e-05	0.000474	CcSEcCtD
Ixabepilone—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	9.24e-05	0.000473	CcSEcCtD
Ixabepilone—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	9.23e-05	0.000472	CcSEcCtD
Ixabepilone—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	9.17e-05	0.00047	CcSEcCtD
Ixabepilone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	9.17e-05	0.000469	CcSEcCtD
Ixabepilone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	9.14e-05	0.000468	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	8.99e-05	0.00046	CcSEcCtD
Ixabepilone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	8.93e-05	0.000457	CcSEcCtD
Ixabepilone—Nausea—Dactinomycin—peripheral nervous system neoplasm	8.88e-05	0.000455	CcSEcCtD
Ixabepilone—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	8.85e-05	0.000453	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	8.85e-05	0.000453	CcSEcCtD
Ixabepilone—Dizziness—Vincristine—peripheral nervous system neoplasm	8.83e-05	0.000452	CcSEcCtD
Ixabepilone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	8.81e-05	0.000451	CcSEcCtD
Ixabepilone—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	8.8e-05	0.00045	CcSEcCtD
Ixabepilone—Infestation—Doxorubicin—peripheral nervous system neoplasm	8.8e-05	0.00045	CcSEcCtD
Ixabepilone—Rash—Alitretinoin—peripheral nervous system neoplasm	8.74e-05	0.000447	CcSEcCtD
Ixabepilone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	8.73e-05	0.000447	CcSEcCtD
Ixabepilone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	8.7e-05	0.000445	CcSEcCtD
Ixabepilone—Headache—Alitretinoin—peripheral nervous system neoplasm	8.68e-05	0.000445	CcSEcCtD
Ixabepilone—Renal failure—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.000443	CcSEcCtD
Ixabepilone—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	8.63e-05	0.000442	CcSEcCtD
Ixabepilone—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	8.58e-05	0.000439	CcSEcCtD
Ixabepilone—Jaundice—Doxorubicin—peripheral nervous system neoplasm	8.58e-05	0.000439	CcSEcCtD
Ixabepilone—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	8.58e-05	0.000439	CcSEcCtD
Ixabepilone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	8.55e-05	0.000438	CcSEcCtD
Ixabepilone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	8.55e-05	0.000438	CcSEcCtD
Ixabepilone—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	8.55e-05	0.000438	CcSEcCtD
Ixabepilone—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	8.54e-05	0.000437	CcSEcCtD
Ixabepilone—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	8.49e-05	0.000435	CcSEcCtD
Ixabepilone—Vomiting—Vincristine—peripheral nervous system neoplasm	8.49e-05	0.000435	CcSEcCtD
Ixabepilone—Asthenia—Cisplatin—peripheral nervous system neoplasm	8.47e-05	0.000434	CcSEcCtD
Ixabepilone—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	8.43e-05	0.000432	CcSEcCtD
Ixabepilone—Rash—Vincristine—peripheral nervous system neoplasm	8.42e-05	0.000431	CcSEcCtD
Ixabepilone—Dermatitis—Vincristine—peripheral nervous system neoplasm	8.41e-05	0.000431	CcSEcCtD
Ixabepilone—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	8.39e-05	0.000429	CcSEcCtD
Ixabepilone—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	8.37e-05	0.000428	CcSEcCtD
Ixabepilone—Headache—Vincristine—peripheral nervous system neoplasm	8.37e-05	0.000428	CcSEcCtD
Ixabepilone—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	8.32e-05	0.000426	CcSEcCtD
Ixabepilone—Nausea—Alitretinoin—peripheral nervous system neoplasm	8.23e-05	0.000421	CcSEcCtD
Ixabepilone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	8.08e-05	0.000414	CcSEcCtD
Ixabepilone—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.000413	CcSEcCtD
Ixabepilone—Eye disorder—Epirubicin—peripheral nervous system neoplasm	7.98e-05	0.000408	CcSEcCtD
Ixabepilone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	7.97e-05	0.000408	CcSEcCtD
Ixabepilone—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	7.94e-05	0.000406	CcSEcCtD
Ixabepilone—Nausea—Vincristine—peripheral nervous system neoplasm	7.93e-05	0.000406	CcSEcCtD
Ixabepilone—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	7.92e-05	0.000406	CcSEcCtD
Ixabepilone—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	7.9e-05	0.000404	CcSEcCtD
Ixabepilone—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	7.86e-05	0.000402	CcSEcCtD
Ixabepilone—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	7.8e-05	0.000399	CcSEcCtD
Ixabepilone—Asthenia—Etoposide—peripheral nervous system neoplasm	7.76e-05	0.000397	CcSEcCtD
Ixabepilone—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	7.76e-05	0.000397	CcSEcCtD
Ixabepilone—Angiopathy—Epirubicin—peripheral nervous system neoplasm	7.75e-05	0.000396	CcSEcCtD
Ixabepilone—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	7.74e-05	0.000396	CcSEcCtD
Ixabepilone—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	7.71e-05	0.000395	CcSEcCtD
Ixabepilone—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	7.69e-05	0.000394	CcSEcCtD
Ixabepilone—Chills—Epirubicin—peripheral nervous system neoplasm	7.66e-05	0.000392	CcSEcCtD
Ixabepilone—Pruritus—Etoposide—peripheral nervous system neoplasm	7.66e-05	0.000392	CcSEcCtD
Ixabepilone—Alopecia—Epirubicin—peripheral nervous system neoplasm	7.54e-05	0.000386	CcSEcCtD
Ixabepilone—Vomiting—Cisplatin—peripheral nervous system neoplasm	7.51e-05	0.000384	CcSEcCtD
Ixabepilone—Mental disorder—Epirubicin—peripheral nervous system neoplasm	7.48e-05	0.000383	CcSEcCtD
Ixabepilone—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.000382	CcSEcCtD
Ixabepilone—Rash—Cisplatin—peripheral nervous system neoplasm	7.45e-05	0.000381	CcSEcCtD
Ixabepilone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	7.44e-05	0.000381	CcSEcCtD
Ixabepilone—Malnutrition—Epirubicin—peripheral nervous system neoplasm	7.43e-05	0.00038	CcSEcCtD
Ixabepilone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	7.4e-05	0.000379	CcSEcCtD
Ixabepilone—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	7.38e-05	0.000378	CcSEcCtD
Ixabepilone—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	7.33e-05	0.000375	CcSEcCtD
Ixabepilone—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	7.17e-05	0.000367	CcSEcCtD
Ixabepilone—Dizziness—Etoposide—peripheral nervous system neoplasm	7.16e-05	0.000366	CcSEcCtD
Ixabepilone—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	7.15e-05	0.000366	CcSEcCtD
Ixabepilone—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	7.14e-05	0.000365	CcSEcCtD
Ixabepilone—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.12e-05	0.000364	CcSEcCtD
Ixabepilone—Chills—Doxorubicin—peripheral nervous system neoplasm	7.09e-05	0.000363	CcSEcCtD
Ixabepilone—Nausea—Cisplatin—peripheral nervous system neoplasm	7.02e-05	0.000359	CcSEcCtD
Ixabepilone—Alopecia—Doxorubicin—peripheral nervous system neoplasm	6.98e-05	0.000357	CcSEcCtD
Ixabepilone—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	6.92e-05	0.000354	CcSEcCtD
Ixabepilone—Vomiting—Etoposide—peripheral nervous system neoplasm	6.88e-05	0.000352	CcSEcCtD
Ixabepilone—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	6.88e-05	0.000352	CcSEcCtD
Ixabepilone—Anaemia—Epirubicin—peripheral nervous system neoplasm	6.87e-05	0.000352	CcSEcCtD
Ixabepilone—Rash—Etoposide—peripheral nervous system neoplasm	6.82e-05	0.000349	CcSEcCtD
Ixabepilone—Dermatitis—Etoposide—peripheral nervous system neoplasm	6.82e-05	0.000349	CcSEcCtD
Ixabepilone—Headache—Etoposide—peripheral nervous system neoplasm	6.78e-05	0.000347	CcSEcCtD
Ixabepilone—Syncope—Epirubicin—peripheral nervous system neoplasm	6.66e-05	0.000341	CcSEcCtD
Ixabepilone—Leukopenia—Epirubicin—peripheral nervous system neoplasm	6.65e-05	0.000341	CcSEcCtD
Ixabepilone—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	6.61e-05	0.000338	CcSEcCtD
Ixabepilone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	6.53e-05	0.000334	CcSEcCtD
Ixabepilone—Cough—Epirubicin—peripheral nervous system neoplasm	6.49e-05	0.000332	CcSEcCtD
Ixabepilone—Nausea—Etoposide—peripheral nervous system neoplasm	6.43e-05	0.000329	CcSEcCtD
Ixabepilone—Anaemia—Doxorubicin—peripheral nervous system neoplasm	6.36e-05	0.000325	CcSEcCtD
Ixabepilone—Myalgia—Epirubicin—peripheral nervous system neoplasm	6.33e-05	0.000324	CcSEcCtD
Ixabepilone—Arthralgia—Epirubicin—peripheral nervous system neoplasm	6.33e-05	0.000324	CcSEcCtD
Ixabepilone—Chest pain—Epirubicin—peripheral nervous system neoplasm	6.33e-05	0.000324	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	6.28e-05	0.000322	CcSEcCtD
Ixabepilone—Syncope—Doxorubicin—peripheral nervous system neoplasm	6.17e-05	0.000316	CcSEcCtD
Ixabepilone—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	6.16e-05	0.000315	CcSEcCtD
Ixabepilone—Oedema—Epirubicin—peripheral nervous system neoplasm	6.07e-05	0.00031	CcSEcCtD
Ixabepilone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	6.04e-05	0.000309	CcSEcCtD
Ixabepilone—Infection—Epirubicin—peripheral nervous system neoplasm	6.03e-05	0.000308	CcSEcCtD
Ixabepilone—Cough—Doxorubicin—peripheral nervous system neoplasm	6e-05	0.000307	CcSEcCtD
Ixabepilone—Shock—Epirubicin—peripheral nervous system neoplasm	5.97e-05	0.000305	CcSEcCtD
Ixabepilone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	5.95e-05	0.000304	CcSEcCtD
Ixabepilone—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	5.94e-05	0.000304	CcSEcCtD
Ixabepilone—Skin disorder—Epirubicin—peripheral nervous system neoplasm	5.89e-05	0.000302	CcSEcCtD
Ixabepilone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	5.85e-05	0.0003	CcSEcCtD
Ixabepilone—Chest pain—Doxorubicin—peripheral nervous system neoplasm	5.85e-05	0.0003	CcSEcCtD
Ixabepilone—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	5.85e-05	0.0003	CcSEcCtD
Ixabepilone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	5.81e-05	0.000298	CcSEcCtD
Ixabepilone—Anorexia—Epirubicin—peripheral nervous system neoplasm	5.78e-05	0.000296	CcSEcCtD
Ixabepilone—Hypotension—Epirubicin—peripheral nervous system neoplasm	5.67e-05	0.00029	CcSEcCtD
Ixabepilone—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.61e-05	0.000287	CcSEcCtD
Ixabepilone—Infection—Doxorubicin—peripheral nervous system neoplasm	5.58e-05	0.000285	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.53e-05	0.000283	CcSEcCtD
Ixabepilone—Shock—Doxorubicin—peripheral nervous system neoplasm	5.52e-05	0.000283	CcSEcCtD
Ixabepilone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	5.5e-05	0.000282	CcSEcCtD
Ixabepilone—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	5.49e-05	0.000281	CcSEcCtD
Ixabepilone—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.49e-05	0.000281	CcSEcCtD
Ixabepilone—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	5.45e-05	0.000279	CcSEcCtD
Ixabepilone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.45e-05	0.000279	CcSEcCtD
Ixabepilone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	5.41e-05	0.000277	CcSEcCtD
Ixabepilone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	5.35e-05	0.000274	CcSEcCtD
Ixabepilone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.27e-05	0.00027	CcSEcCtD
Ixabepilone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	5.24e-05	0.000268	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	5.24e-05	0.000268	CcSEcCtD
Ixabepilone—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.23e-05	0.000268	CcSEcCtD
Ixabepilone—Pain—Epirubicin—peripheral nervous system neoplasm	5.19e-05	0.000266	CcSEcCtD
Ixabepilone—Constipation—Epirubicin—peripheral nervous system neoplasm	5.19e-05	0.000266	CcSEcCtD
Ixabepilone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.11e-05	0.000262	CcSEcCtD
Ixabepilone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.08e-05	0.00026	CcSEcCtD
Ixabepilone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.04e-05	0.000258	CcSEcCtD
Ixabepilone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	5e-05	0.000256	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.96e-05	0.000254	CcSEcCtD
Ixabepilone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.88e-05	0.00025	CcSEcCtD
Ixabepilone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.85e-05	0.000248	CcSEcCtD
Ixabepilone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.84e-05	0.000248	CcSEcCtD
Ixabepilone—Pain—Doxorubicin—peripheral nervous system neoplasm	4.8e-05	0.000246	CcSEcCtD
Ixabepilone—Constipation—Doxorubicin—peripheral nervous system neoplasm	4.8e-05	0.000246	CcSEcCtD
Ixabepilone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000245	CcSEcCtD
Ixabepilone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000245	CcSEcCtD
Ixabepilone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.000235	CcSEcCtD
Ixabepilone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.47e-05	0.000229	CcSEcCtD
Ixabepilone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.44e-05	0.000227	CcSEcCtD
Ixabepilone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.44e-05	0.000227	CcSEcCtD
Ixabepilone—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.35e-05	0.000223	CcSEcCtD
Ixabepilone—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.29e-05	0.00022	CcSEcCtD
Ixabepilone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.15e-05	0.000212	CcSEcCtD
Ixabepilone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.13e-05	0.000212	CcSEcCtD
Ixabepilone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.000206	CcSEcCtD
Ixabepilone—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.01e-05	0.000205	CcSEcCtD
Ixabepilone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.97e-05	0.000203	CcSEcCtD
Ixabepilone—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.86e-05	0.000197	CcSEcCtD
Ixabepilone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.84e-05	0.000197	CcSEcCtD
Ixabepilone—Rash—Epirubicin—peripheral nervous system neoplasm	3.82e-05	0.000196	CcSEcCtD
Ixabepilone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.82e-05	0.000196	CcSEcCtD
Ixabepilone—Headache—Epirubicin—peripheral nervous system neoplasm	3.8e-05	0.000195	CcSEcCtD
Ixabepilone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.71e-05	0.00019	CcSEcCtD
Ixabepilone—Nausea—Epirubicin—peripheral nervous system neoplasm	3.6e-05	0.000184	CcSEcCtD
Ixabepilone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.57e-05	0.000183	CcSEcCtD
Ixabepilone—Rash—Doxorubicin—peripheral nervous system neoplasm	3.54e-05	0.000181	CcSEcCtD
Ixabepilone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.54e-05	0.000181	CcSEcCtD
Ixabepilone—Headache—Doxorubicin—peripheral nervous system neoplasm	3.52e-05	0.00018	CcSEcCtD
Ixabepilone—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.33e-05	0.000171	CcSEcCtD
